logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

ER/PR+ node+ breast cancer: 21-gene recurrence score is an independent predictor

Retrospective analysis of phase 3 Southwest Oncology Group S8814 can aid in radiotherapy decisions.